Clinical Advances in Pediatric Oncology Seminar Series

Doctor with young oncology patient Children's Hospital of Philadelphia (CHOP) is offering a series of free webinars on oncology and oncology-related topics through spring 2021. Experts from CHOP’s Cancer Center, rated the #1 pediatric oncology program in the nation by U.S. News & World Report, will discuss the latest in cancer research and care. You can find more information (including CME credit) and register for any of the individual webinars by clicking on the title below. Or if you would like to register for multiple or all webinars at once, please click here.

 

Nov. 18, 2020, 8–9:30 a.m. (ET)

Innovations in Vascular Anomalies: How a Multidisciplinary Disease Approach Can Change the Outcome for Rare Disease

This lecture will provide an overview of how comprehensive, multidisciplinary care can benefit patients with these complex conditions as well as updates on diagnosis, phenotype/genotype correlation of disease, innovative interventional therapeutics options and translational research underway that can lead to new drug development.

Speakers: Denise Adams, MD; Sarah Sheppard, MD, PhD; Hakon Hakonarson, MD, PhD; Kristen Snyder, MD; Yoav Dori, MD, PhD

 

Nov. 19, 2020, 8–9 a.m. (ET)

Advanced Pediatric Thyroid Cancer: Is It Time for a Paradigm Shift in Care?

Standard therapy for thyroid cancer in children involves surgical resection followed by radioactive iodine therapy in patients with invasive differentiated thyroid carcinoma.  This lecture will provide updates on new therapeutic approaches for treating children with thyroid cancer who have highly advanced disease at diagnosis or thyroid cancer where standard therapy options have failed.

Speaker: Andrew J. Bauer, MD

 

Dec. 15, 2020, 5–6:30 p.m. (ET)

The CAR-T Revolution 3 Years After FDA Approval

This virtual lecture will review outcomes data and provide an update on advancements and new trials in the field of cancer immunotherapy for patients with relapsed acute lymphoblastic leukemia (ALL) and review current immunotherapeutic treatment options for pediatric acute myeloid leukemia (AML). 

Speakers: Stephan A. Grupp, MD, PhD; Richard Aplenc, MD, PhD, MSCE

 

Jan. 15, 2021, 7:30–8:30 a.m. (ET)

Curative and Emerging Therapies for Sickle Cell Disease

In this lecture, we will provide an overview for general practitioners and hematologists about the limitations of current therapies for sickle cell disease, pivotal data leading to the emergence of novel curative therapies – including gene therapies – and approaches to deciding which therapies are optimal for individual patients.

Speakers: Kim Smith-Whitley, MD; Timothy S. Olson, MD, PhD

 

Jan. 19, 2021, 5:30–6:30 p.m. (ET)

Cancer Predisposition and Surveillance in Children and Adolescents

In this webinar, we will present the general approach to patients with a possible cancer predisposition syndrome, review a few of the more common cancer surveillance syndromes, and discuss future directions in the field of pediatric cancer predisposition.

Speakers: Garrett Brodeur, MD; Suzanne Macfarland, MD; Kristin Zelley, MS; Sarah Jennings, MS, LCGC

 

Feb. 4, 2021, noon–1 p.m. (ET)

Optic Pathway Gliomas in Neurofibromatosis Type 1: Clinical Features, Current Management and the Importance of Functional Outcomes

Optic pathway gliomas (OPGs) are low-grade astrocytomas that occur in 15-20% of children with neurofibromatosis type 1 (NF1). Although rarely life-threatening, these tumors can cause significant vision loss. This lecture will discuss the natural history, monitoring, and management of NF1-OPGs, as well as discuss emerging therapies to reduce the risk of permanent visual loss. 

Speakers: Michael J. Fisher, MD; Robert A. Avery, DO, MSCE

 

March 19, 2021, 7–8:30 a.m. (ET)

Advances in Multi-Disciplinary Care for Children with High-Risk Neuroblastoma

Survival rates for children with high-risk neuroblastoma have doubled in the past two decades, but this progress has come with the use of lengthy, complex therapy. In this lecture, we will cover the current state of therapy for these patients, the remaining challenges in the areas of surgery, radiation, and medical therapy for children with high-risk disease and new directions in therapeutic strategies.

Speakers: Rochelle Bagatell, MD; Peter Mattei, MD; Christine Hill-Kayser, MD

 

Questions?

Contact Shelly Norbury at 856-397-5588 or norburys@chop.edu.

 

Subscribe to Cancer Connections E-newsletter for Providers

Healthcare professionals are invited to subscribe to Cancer Connections. Stay up to date on our clinical programs, research, clinical trials, educational opportunities, and other information that is important to providers who refer patients to the Cancer Center at Children's Hospital of Philadelphia. Subscribe to Cancer Connections.


Next Steps
New Patients, Referrals and 2nd Opinions
Existing Patients or Family Members
Young boy smiling outside

Get a Second Opinion

Our experts are here to review your child’s diagnosis and treatment plan, and work with primary oncologists as needed.

Oncology patient with Mom

Patient-Family Education

Review educational information for individuals and families facing childhood cancer.